Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0349506 (
photosensitivity
)
4,145
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Genetic differences are involved in the development of lupus erythematosus (LE). Skin lesions are influenced by environmental triggers such as ultraviolet light, temperature, and chemical stresses, and the patterns of skin lesion are variable in cutaneous LE such as systemic LE (SLE), chronic discoid LE (CDLE), subacute cutaneous LE (SCLE), and LE tumidus (LET). Although there are a few conflicting reports, many Japanese dermatologists feel there are
photosensitivity
differences in lupus erythematosus between Asian and Caucasian subjects with SCLE and LET. HLA studies in Japanese subjects revealed that HLA-DRB1*1501 association was with both CDLE and SLE. The association between
HLA-Cw6
and CDLE was first reported in Japanese population, and a HLA-A33-B44-DRB1*1302 haplotype showed a positive association in CDLE. However, these results are not compatible with those from Caucasian subjects. There are no significant associations among HLA studies,
photosensitivity
, and anti-Ro/SS-A antibodies in Japanese CLE patients.
Photosensitivity
will be a key factor to dissolve multi-factorial complexes of LE etiopathogenesis. Our present understanding is that an axis of
photosensitivity
, anti-Ro/SS-A antibodies and apoptosis via TNF are the best (markers) to verify the contribution of genetics in SCLE, LET, and other CLEs. The incidence and
photosensitivity
of SCLE and LET are much lower in Japanese than in Caucasian subjects. However, this discrepancy may open the window for investigating CLE pathogenesis through global collaborations. For this purpose and goal, a new and more conventional method should be developed for the examination of so-called
photosensitivity
.
...
PMID:Ethnic differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus. 1879 90
Skin lesions of collagen diseases are influenced by environmental triggers, such as UV light, and are variable in cutaneous lupus erythematosus (LE), such as systemic LE (SLE), chronic discoid LE (CDLE), subacute cutaneous LE (SCLE), and LE tumidus (LET). Although there are a few conflicting reports on
photosensitivity
in collagen diseases, many Japanese dermatologists feel there are
photosensitivity
differences in LE between Asians and Caucasians with SCLE and LET. To address this issue, we have carried out genetic studies of Japanese SLE and CDLE patients and reviewed the race differences in
photosensitivity
of cutaneous LE from Japanese studies. Human leukocyte antigen (HLA) studies in Japanese patients revealed that HLA-DRB1*1501 association was with CDLE and SLE. The association between
HLA-Cw6
and CDLE was first reported in a Japanese population, and a HLA-A33-B44-DRB1*1302 haplotype showed a positive association in CDLE. However, these results are not compatible with those from Caucasian subjects. There are no significant associations among HLA studies,
photosensitivity
, and anti-Ro/SS-A antibodies in Japanese CLE patients.
Photosensitivity
will be a key factor to dissolve multifactorial complexes of LE etiopathogenesis. An axis of
photosensitivity
, anti-Ro/SS-A antibodies, and apoptosis via tumor necrosis factor-alpha is the best marker to verify the contribution of genetics in CLE patients. The incidence and degree of
photosensitivity
of SCLE and LET are much lower in Japanese than in Caucasians. This discrepancy may lead to investigations of CLE pathogenesis through global collaborations.
...
PMID:Race differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus from the aspect of Japanese studies. 1975 98
Psoriasis is a multifactorial disease with a strong genetic background.
HLA-Cw6
is one of the most strongly associated psoriasis susceptibility alleles. It is repeatedly observed to affect disease course, phenotypic features, severity, comorbidities and treatment outcomes. To the best of our knowledge, the roles of
HLA-Cw6
in psoriasis have not yet been thoroughly reviewed. The worldwide frequency of the
HLA-Cw6
allele varies greatly, with it being generally higher in white people than in Asians. The allele is associated with type I early-onset psoriasis. Stress, obesity and streptococcal pharyngitis are commonly observed in
HLA-Cw6
-positive patients. Phenotypically,
HLA-Cw6
has been found to be associated with guttate psoriasis. In addition, patients carrying the allele are more likely to have arm, leg and trunk involvement, and the Koebner phenomenon. Patients with psoriatic arthritis with
HLA-Cw6
more often have early onset and tend to show cutaneous symptoms before musculoskeletal symptoms.
HLA-Cw6
-positive patients have been shown in several studies to be more responsive to methotrexate and ustekinumab. However, this difference in ustekinumab efficacy was only moderate in a post-hoc analysis of a pivotal phase III study.
HLA-Cw6
positivity also tends to be less frequent in high-need patients who fail conventional therapy. Small studies have also investigated the role of
HLA-Cw6
in remission of psoriasis during pregnancy, and with the comorbidities of
photosensitivity
and atherosclerosis. Given the diverse nature of psoriasis pathogenesis, as well as the difference of
HLA-Cw6
positivity in different ethnic groups, more studies are needed to confirm the role of
HLA-Cw6
in psoriasis.
...
PMID:HLA-Cw6 and psoriasis. 2966 91